27
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic, Chicago, IL

      editorial

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The COVID-19 pandemic has the potential to lead to serious negative health outcomes for people living with HIV (PLWH). Besides the risk of COVID-19 disease itself, the indirect effects of the pandemic including shelter-in-place orders, record unemployment, and widespread social anxiety may interact synergistically to worsen health outcomes for PLWH [1, 2]. In this report, we share the experience from University of Chicago Medicine regarding the early impact of the COVID-19 pandemic on PLWH in regards to retention in care, antiretroviral adherence, and COVID-19 testing and clinical outcomes. Retention in Care Retention in care is essential for the health of PLWH and for public health [3]. Patients who are retained in care are more likely to adhere to antiretroviral therapy and experience improved health outcomes, and are less likely to transmit HIV to others [4]. Missed medical appointments are independently associated with increased risk of AIDS-defining illnesses and death [5, 6]. Traditionally, retention in care has relied on the ability of PLWH to regularly attend in-person appointments with their HIV medical team, which is difficult during the COVID-19 pandemic. To slow the spread of COVID-19, the Centers for Disease Control and Prevention (CDC) has strongly encouraged social distancing [7] and many U.S. state governments have imposed shelter-in-place or “lockdown” orders [8–10]. In response, the HRSA Ryan White Program has encouraged the use of telehealth to allow PLWH to stay home and not travel to clinics for HIV care visits [11], and many HIV medical providers have moved to virtual medical visits utilizing telephone calls or online video conferencing services. While virtual visits are helpful for some PLWH [12, 13], others may may not have reliable internet or mobile phone services to utilize these services [14]. Moreover, during the pandemic, many Infectious Diseases physicians and clinics are overwhelmed with COVID-19 patients, and lack the time or resources to respond to PLWH who may have additional needs or concerns during this time. Services and resources which in ordinary times are easily available may have been discontinued, with effects on reengagement in care and extension of prescriptions. Even if telephone or video conferencing visits are occurring, these visits may lack wrap around services provided by social workers and other HIV care team members. Our medical center serves a predominantly African American population from economically disadvantaged areas on the south side of Chicago and is a major provider of HIV care in our community [15]. We began the process of converting in-person HIV care visits to telephone or video conferencing calls immediately after the state of Illinois imposed a “shelter in place” order on March 21, 2020 [8]. To best meet the needs of our patients, our clinic utilized a two-tiered approach of either delaying visits several months in the future, or arranging virtual visits. During the first 4 weeks of the order (March 21, 2020 through April 17, 2020), 98 PLWH were scheduled for HIV care visits in our clinic. Of these, 2.0% (2/98) attended in-person visits, 21.4% (21/98) attended virtual visits with a member of the HIV care team, and 30.6% (30/98) rescheduled for a later date. Among the 45 PLWH who neither attended virtual visits nor were rescheduled, 60% (27/45) had a most recent HIV viral load (VL) < 20 copies/mL, 31.1% (14/45) had VL between 20 and 200 copies/mL, and 8.9% (4/45) patients had VL > 200 copies/mL. PLWH whose appointments were rescheduled or cancelled were more likely to have VL < 20 copies/mL than those who attended in-person or virtual visits (89.3%, (67/75) vs. 39.1%, (9/23)). This finding is encouraging, suggesting that providers prioritized visits with patients with detectable viral loads who were most in need of close follow-up. Ideally all patients would have the opportunity to connect with their HIV care providers, and we are in the process of reaching out to PLWH who neither attended visits nor rescheduled to arrange virtual visits. ART Access and Adherence Limited access and adherence to antiretroviral therapy are other possible hazards for PLWH during COVID-19. The pandemic has led to record-breaking unemployment claims and financial stress [16], including loss of health insurance, increased food insecurity, and fears of homelessness. Direct loss of income and prescription coverage may lead to PWLH not being able to afford or access medications. State AIDS Drugs Assistance Programs (ADAP) have recognized this barrier and modified the criteria for renewals and loosened the restrictions for submission [11]. Our clinic has increased mail delivery for prescriptions and extended refills while patients are not able to come in for laboratory testing. Our social work team has provided gift cards for grocery and supply stores in order to combat food insecurity—mailing or dropping off resources as needed. Worsening of behavioral health disorders in the setting of the COVID-19 pandemic can also lead to decreased ART adherence. Many PLWH are disproportionately affected by mental health and substance use disorders [17–22], which may be exacerbated due to the uncertainty and anxiety caused by the pandemic [23]. We have mobilized our behavioral health program to provide more frequent, brief tele-therapy supports to provide continuity of mental healthcare. Although some patients prefer in-person contact and have temporarily discontinued services, we have seen in an increase in participation from patients who historically have not engaged in therapy services. Our programs have also created interactive video conference workshops and question and answer sessions for patients and community members who do not want to engage in individual therapy, but are in need additional support during this time. COVID-19 Testing and Clinical Outcomes Among PLWH It is unknown if PLWH are at increased risk for infection and severe outcomes from COVID-19. Early reports from China suggest similar rates of infection to the rest of the population [24]. However, in the United States, many PLWH come from economically disadvantaged backgrounds who are more likely to work jobs considered essential and remain at increased risk for SARS-CoV-2 exposure during social distancing [25, 26]. Recent studies also suggest that COVID-19 is more common among African American and Latinx populations, groups with higher prevalence of HIV in the US [27, 28]. Additionally, comorbid diseases that are common among PLWH, such as cardiovascular disease may lead to worse COVID-19 outcomes [29]. Given the higher prevalence of comorbid conditions and membership in communities that suffer from structural inequities, it remains to be seen if PLWH suffer disproportionately from COVID-19. To date, our medical center has not seen higher rates of COVID-19 among PLWH. Between March 12 and April 17, 2020, 5,537 patients were tested for COVID-19. Of these, 55 (1.0%) were PLWH, of whom 8 tested positive for COVID-19 (14.5%). Of HIV-negative patients tested for COVID-19, 1061/5482(19.4%) were positive (Chi-square p-value = 0.37), showing no significant difference in testing positive for COVID-19 based on HIV status. Among the 8 PLWH with COVID-19, 75% (6/8) were hospitalized, 12.5% (1/8) required admission to the intensive care unit, and none have died. Conclusion The COVID-19 pandemic has the potential to greatly disrupt HIV care continuum outcomes among PLWH. As we experience unprecedented financial stressors and necessary changes to our healthcare delivery system, we must adapt our care and services to continue to engage PLWH to avoid poor outcomes amongst our more vulnerable patients. Prioritizing patients who are not virally suppressed may serve as a successful strategy for preventing patients from falling off the HIV care continuum. Additional and timely resources are needed to provide rapid ART access and to combat food insecurity and homelessness. Healthcare services must be creatively adapted to support physical and mental health remotely to meet individual and community needs. While we are not currently seeing disproportionate COVID-19 among PLWH, we continue to monitor those outcomes. More research is needed to know the long-term implications of the pandemic for the health of people living with HIV.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          Patients with mental health disorders in the COVID-19 epidemic

          More than 60 000 infections have been confirmed worldwide in the coronavirus disease 2019 (COVID-19) epidemic, with most of these cases in China. Global attention has largely been focused on the infected patients and the frontline responders, with some marginalised populations in society having been overlooked. Here, we write to express our concerns with regards to the effect of the epidemic on people with mental health disorders. Ignorance of the differential impact of the epidemic on these patients will not only hinder any aims to prevent further spread of COVID-19, but will also augment already existing health inequalities. In China, 173 million people are living with mental health disorders, 1 and neglect and stigma regarding these conditions still prevail in society. 2 When epidemics arise, people with mental health disorders are generally more susceptible to infections for several reasons. First, mental health disorders can increase the risk of infections, including pneumonia. 3 One report released on Feb 9, 2020, discussing a cluster of 50 cases of COVID-19 among inpatients in one psychiatric hospital in Wuhan, China, has raised concerns over the role of mental disorders in coronavirus transmission. 4 Possible explanations include cognitive impairment, little awareness of risk, and diminished efforts regarding personal protection in patients, as well as confined conditions in psychiatric wards. Second, once infected with severe acute respiratory syndrome coronavirus 2—which results in COVID-19—people with mental disorders can be exposed to more barriers in accessing timely health services, because of discrimination associated with mental ill-health in health-care settings. Additionally, mental health disorder comorbidities to COVID-19 will make the treatment more challenging and potentially less effective. 5 Third, the COVID-19 epidemic has caused a parallel epidemic of fear, anxiety, and depression. People with mental health conditions could be more substantially influenced by the emotional responses brought on by the COVID-19 epidemic, resulting in relapses or worsening of an already existing mental health condition because of high susceptibility to stress compared with the general population. Finally, many people with mental health disorders attend regular outpatient visits for evaluations and prescriptions. However, nationwide regulations on travel and quarantine have resulted in these regular visits becoming more difficult and impractical to attend. Few voices of this large but vulnerable population of people with mental health disorders have been heard during this epidemic. Epidemics never affect all populations equally and inequalities can always drive the spread of infections. As mental health and public health professionals, we call for adequate and necessary attention to people with mental health disorders in the COVID-19 epidemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

            Each of 10 published studies investigating the relationship between HIV infection and risk for depressive disorders concluded that HIV-positive individuals are at no greater risk for depression than comparable HIV-negative individuals. This study used meta-analytic techniques to further examine the relationship between depressive disorders and HIV infection. Meta-analytic techniques were used to aggregate and reanalyze the data from 10 studies that compared HIV-positive and HIV-negative individuals for rates of major depressive disorder (N=2,596) or dysthymic disorder (N=1,822). The frequency of major depressive disorder was nearly two times higher in HIV-positive subjects than in HIV-negative comparison subjects. On the other hand, findings were inconclusive with regard to dysthymic disorder. Rates of depression do not appear to be related to the sexual orientation or disease stage of infected individuals. Although the majority of HIV-positive individuals appear to be psychologically resilient, this meta-analysis provides strong evidence that HIV infection is associated with a greater risk for major depressive disorder. Future research should focus on identifying pathways of risk and resilience for depression within this population.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The therapeutic implications of timely linkage and early retention in HIV care.

              Following HIV diagnosis, linkage to outpatient treatment, antiretroviral initiation, and longitudinal retention in care represent the foundation for successful treatment. While prior studies have evaluated these processes in isolation, a systematic evaluation of successive steps in the same cohort of patients has not yet been performed. To ensure optimal long-term outcomes, a better understanding of the interplay of these processes is needed. Therefore, a retrospective cohort study of patients initiating outpatient care at the University of Alabama at Birmingham 1917 HIV=AIDS Clinic between January 2000 and December 2005 was undertaken. Multivariable models determined factors associated with: late diagnosis=linkage to care (initial CD4 < 350 cells=mm3), timely antiretroviral initiation, and retention across the first two years of care. Delayed linkage was observed in two-thirds of the overall sample (n = 567) and was associated with older age (odds ratio [OR] = 1.31 per 10 years; 95%confidence interval [CI] = 1.06-1.62) and African American race (OR = 2.45; 95% CI = 1.60-3.74). Attending all clinic visits (hazard ratio [HR] = 6.45; 95% CI = 4.47-9.31) and lower initial CD4 counts led to earlier antiretroviral initiation. Worse retention in the first 2 years was associated with younger age (OR = 0.68 per 10 years;95% CI = 0.56-0.83), higher baseline CD4 count, and substance abuse (OR = 1.78; 95% CI = 1.16-2.73). Interventions to improve timely HIV diagnosis and linkage to care should focus on older patients and African Americans while efforts to improve retention should address younger patients, those with higher baseline CD4 counts, and substance abuse. Missed clinic visits represent an important obstacle to the timely initiation of antiretroviral therapy. These data inform development of interventions to improve linkage and retention in HIV care, an emerging area of growing importance.
                Bookmark

                Author and article information

                Contributors
                jridgway@medicine.bsd.uchicago.edu
                Journal
                AIDS Behav
                AIDS Behav
                AIDS and Behavior
                Springer US (New York )
                1090-7165
                1573-3254
                7 May 2020
                : 1-3
                Affiliations
                GRID grid.170205.1, ISNI 0000 0004 1936 7822, Department of Medicine, , University of Chicago, ; Chicago, IL USA
                Article
                2905
                10.1007/s10461-020-02905-2
                7203502
                32382823
                51f7724f-3095-4b4d-b4e2-4c08fde04b8c
                © Springer Science+Business Media, LLC, part of Springer Nature 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Notes From The Field

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article